Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer

  • Tomasz Huzarski1,
  • Barbara Górecka-Szyld2, 3,
  • Jowita Huzarska1,
  • Grażyna Psut-Muszyńska2, 3,
  • Grażyna Wilk2,
  • Robert Sibilski4,
  • Cezary Cybulski1,
  • Beata Kozak-Klonowska5,
  • Monika Siołek5,
  • Ewa Kilar6,
  • Dorota Czudowska7,
  • Hanna Janiszewska8,
  • Dariusz Godlewski9,
  • Andrzej Mackiewicz10,
  • Joanna Jarkiewicz-Tretyn11,
  • Jadwiga Szabo-Moskal12,
  • Jacek Gronwald1,
  • Jan Lubiński1,
  • Steven A. Narod13Email author and
  • the Polish Hereditary Breast Cancer Study Group
Contributed equally
Hereditary Cancer in Clinical Practice201715:4

DOI: 10.1186/s13053-017-0064-y

Received: 11 November 2016

Accepted: 11 February 2017

Published: 1 March 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
11 Nov 2016 Submitted Original manuscript
2 Dec 2016 Reviewed Reviewer Report - D Gareth Evans
12 Dec 2016 Reviewed Reviewer Report - Karin Kast
30 Jan 2017 Author responded Author comments - Tomasz Huzarski
Resubmission - Version 2
30 Jan 2017 Submitted Manuscript version 2
Publishing
11 Feb 2017 Editorially accepted
1 Mar 2017 Article published 10.1186/s13053-017-0064-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University
(2)
Department of Radiology, Pomeranian Medical University
(3)
Euro-Medic Diagnostics Poland Ltd
(4)
Oncology Diagnostic Center
(5)
Regional Oncology Center
(6)
Department of Oncology, District Specialist Hospital
(7)
Oncology Diagnostic Center
(8)
Department of Clinical Genetics, Collegium Medicum, Nicolaus Copernicus University
(9)
Prophylactic and Epidemiology Cancer Center
(10)
Department of Cancer Immunology, Poznan University of Medical Sciences, Greater Poland Cancer Centre
(11)
District Specialist Hospital
(12)
Department of Radiology, Regional Oncology Hospital
(13)
Women’s College Research Institute, Women’s College Hospital and the University of Toronto

Advertisement